Recently, Saito et al. discovered that heat shock transcription factor 4 (HSF4) is elevated in SR RCC cells and the combination of pazopanib with HSF4 knockdown reduced cell proliferation in SR cells[90]. This evidence concerns the gene HSF4 and renal cell carcinoma.